Category: Health & Medicines > Medicines > Atorvastatin
Country/Region: China State/Province: Jiangsu
Main Products: Gefitinib
Business Type: Exporter, Retailer
Year Established: 2010
Employees: 101 - 200 People
Plant Area: 30,000-50,000 square meters
Main Markets: South America 8% Africa 12% Eastern Asia 9% Domestic Market 9% North America 9% Eastern Europe 10% Southern Europe 11% Mid East 12% Northern Europe 11% Oceania 9%
Trade Capacity: FOB, FAS, Express Delivery
Contract Manufacturing: OEM Service Offered
Nearest Port: Nanjing
Annual Revenue: US$5 Million - US$10 Million
Total Revenue: US$2.5 Million - US$5 Million
Export Revenue: US$10 Million - US$50 Million
Annual Output: US$10 Million - US$50 Million
Registered Capital: Below US$1 Million
Export Percentage: 71% - 80%
Payment Modes: USD, CAD, GBP
Lead Time: 33 days
Import/Export Mode: Have Own Export License